tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Compare Enliven Therapeutics (ELVN) vs. Competitors

331 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$45.32
$2.71B
-8.42
203.96%
6 Buy
0 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$21.18
$2.22B
-1.99
-57.90%
7 Buy
13 Hold
5 Sell
Hold
Viridian Therapeutics
$14.95
$1.53B
-5.48
31.03%
13 Buy
1 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$13.49
$1.59B
-2.54
99.26%
8 Buy
8 Hold
1 Sell
Moderate Buy
AbCellera Biologics
$3.54
$1.07B
-6.98
71.01%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ELVN
Enliven Therapeutics
45.32
28.13
163.64%
SRPT
Sarepta Therapeutics
21.18
-33.45
-61.23%
VRDN
Viridian Therapeutics
14.95
1.65
12.41%
CDTX
NTLA
Intellia Therapeutics
13.49
5.99
79.87%
ABCL
AbCellera Biologics
3.54
1.10
45.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts